Clinical and cost effectiveness of a new hepatocellular MRI contrast agent, mangafodipir trisodium, in the preoperative assessment of liver resectability (Q43709237)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Clinical and cost effectiveness of a new hepatocellular MRI contrast agent, mangafodipir trisodium, in the preoperative assessment of liver resectability |
scientific article |
Statements
1 reference
Clinical and cost effectiveness of a new hepatocellular MRI contrast agent, mangafodipir trisodium, in the preoperative assessment of liver resectability (English)
1 reference
Mann GN
1 reference
Marx HF
1 reference
Lai LL
1 reference
Wagman LD
1 reference
1 August 2001
1 reference
1 reference
Identifiers
1 reference